Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Comput Biol Med ; 174: 108454, 2024 May.
Article in English | MEDLINE | ID: mdl-38608326

ABSTRACT

BACKGROUND: Effective and timely detection is vital for mitigating the severe impacts of Sexually Transmitted Infections (STI), including syphilis and HIV. Cyclic Voltammetry (CV) sensors have shown promise as diagnostic tools for these STI, offering a pathway towards cost-effective solutions in primary health care settings. OBJECTIVE: This study aims to pioneer the use of Fourier Descriptors (FDs) in analyzing CV curves as 2D closed contours, targeting the simultaneous detection of syphilis and HIV. METHODS: Raw CV signals are filtered, resampled, and transformed into 2D closed contours for FD extraction. Essential shape characteristics are captured through selected coefficients. A complementary geometrical analysis further extracts features like curve areas and principal axes lengths from CV curves. A Mahalanobis Distance Classifier is employed for differentiation between patient and control groups. RESULTS: The evaluation of the proposed method revealed promising results with classification performance metrics such as Accuracy and F1-Score consistently achieving values rounded to 0.95 for syphilis and 0.90 for HIV. These results underscore the potential efficacy of the proposed approach in differentiating between patient and control samples for STI detection. CONCLUSION: By integrating principles from biosensors, signal processing, image processing, machine learning, and medical diagnostics, this study presents a comprehensive approach to enhance the detection of both syphilis and HIV. This setts the stage for advanced and accessible STI diagnostic solutions.


Subject(s)
HIV Infections , Syphilis , Humans , Syphilis/diagnosis , HIV Infections/diagnosis , Fourier Analysis , Electrochemical Techniques/methods , Signal Processing, Computer-Assisted
2.
Sci Rep ; 13(1): 12865, 2023 08 08.
Article in English | MEDLINE | ID: mdl-37553424

ABSTRACT

Osteoporosis is a disease characterized by impairment of bone microarchitecture that causes high socioeconomic impacts in the world because of fractures and hospitalizations. Although dual-energy X-ray absorptiometry (DXA) is the gold standard for diagnosing the disease, access to DXA in developing countries is still limited due to its high cost, being present only in specialized hospitals. In this paper, we analyze the performance of Osseus, a low-cost portable device based on electromagnetic waves that measures the attenuation of the signal that crosses the medial phalanx of a patient's middle finger and was developed for osteoporosis screening. The analysis is carried out by predicting changes in bone mineral density using Osseus measurements and additional common risk factors used as input features to a set of supervised classification models, while the results from DXA are taken as target (real) values during the training of the machine learning algorithms. The dataset consisted of 505 patients who underwent osteoporosis screening with both devices (DXA and Osseus), of whom 21.8% were healthy and 78.2% had low bone mineral density or osteoporosis. A cross-validation with k-fold = 5 was considered in model training, while 20% of the whole dataset was used for testing. The obtained performance of the best model (Random Forest) presented a sensitivity of 0.853, a specificity of 0.879, and an F1 of 0.859. Since the Random Forest (RF) algorithm allows some interpretability of its results (through the impurity check), we were able to identify the most important variables in the classification of osteoporosis. The results showed that the most important variables were age, body mass index, and the signal attenuation provided by Osseus. The RF model, when used together with Osseus measurements, is effective in screening patients and facilitates the early diagnosis of osteoporosis. The main advantages of such early screening are the reduction of costs associated with exams, surgeries, treatments, and hospitalizations, as well as improved quality of life for patients.


Subject(s)
Osteoporosis , Quality of Life , Humans , Bone Density , Osteoporosis/diagnostic imaging , Absorptiometry, Photon/methods , Mass Screening , Machine Learning , Electromagnetic Radiation
3.
Article in English | MEDLINE | ID: mdl-36498280

ABSTRACT

The improvement of laboratory diagnosis is a critical step for the reduction of syphilis cases around the world. In this paper, we present the development of an impedance-based method for detecting T. pallidum antigens and antibodies as an auxiliary tool for syphilis laboratory diagnosis. We evaluate the voltammetric signal obtained after incubation in carbon or gold nanoparticle-modified carbon electrodes in the presence or absence of Poly-L-Lysine. Our results indicate that the signal obtained from the electrodes was sufficient to distinguish between infected and non-infected samples immediately (T0') or 15 min (T15') after incubation, indicating its potential use as a point-of-care method as a screening strategy.


Subject(s)
Metal Nanoparticles , Syphilis , Humans , Treponema pallidum , Gold , Antibodies, Bacterial , Syphilis/diagnosis , Carbon
4.
J Neonatal Perinatal Med ; 12(1): 9-12, 2019.
Article in English | MEDLINE | ID: mdl-30347623

ABSTRACT

BACKGROUND: Infants with duct-dependent congenital heart lesions are treated with a prostaglandin E1 infusion. We aimed to describe the feeding strategies used at our institution in such infants, and to describe the incidence of necrotising enterocolitis (NEC) in this patient group, investigating whether enteral feeding is associated with a higher risk. METHODS: Patients diagnosed with hypoplastic left heart syndrome, coarctation of the aorta, pulmonary atresia, or transposition of the great arteries born over a defined period were identified. Premature infants, those with pre-existing gastrointestinal disease, and those who never received prostaglandin were excluded. Data were compared using univariable and multivariable logistic regression models. RESULTS: A total of 177 patients were identified, of them 18 received a diagnosis of suspected or confirmed NEC. There was no association between the diagnosis of NEC and enteral feeding (P = 0.9). CONCLUSIONS: Based on these data, there does not appear to be an association between enteral feeding and NEC in infants receiving prostaglandin.


Subject(s)
Enteral Nutrition , Heart Defects, Congenital/therapy , Alprostadil/therapeutic use , Enteral Nutrition/adverse effects , Enteral Nutrition/statistics & numerical data , Enterocolitis, Necrotizing/etiology , Enterocolitis, Necrotizing/physiopathology , Female , Heart Defects, Congenital/physiopathology , Humans , Incidence , Infant , Infant, Newborn , Infant, Premature , Male , Platelet Aggregation Inhibitors/therapeutic use , Retrospective Studies , Risk Factors
5.
Infez Med ; 14(2): 77-84, 2006 Jun.
Article in Italian | MEDLINE | ID: mdl-16891852

ABSTRACT

The Infectious Diseases Unit of Lucca Hospital conducted a multicentric retrospective study to evaluate the epidemiological and clinical features of adult patients affected by bacterial meningitis attending all the Infectious Diseases Units of Tuscany (Italy) from July 1999 to June 2004. A specific questionnaire was sent to all the units to collect information about each case of bacterial meningitis occurring in patients older than sixteen. Patients with meningitis by Mycobacterium tuberculosis were excluded from the analysis. Nine out of 12 Infectious Diseases Units of Tuscany took part in the study and 197 cases were identified. Most cases of meningitis occurred during 2002 with a slight reduction in cases in subsequent years. Streptococcus pneumoniae and Neisseria meningitidis were the most frequently isolated pathogens with an increase in diagnosis from 1999 to 2004; in 23.8% of patients no pathogens were isolated, with a reduction in meningitis from unknown aetiology from 1999 to 2004. Most patients were treated with a combination of two antibiotics, and corticosteroid drugs were added to the therapy; in the group of patients treated with corticosteroid drugs invalidating complications occurred in 23% of cases and 5% of patients died. In all, 27 out of 197 subjects (13.7%) developed invalidating complications and 20 out of 197 patients (10.2%) died.


Subject(s)
Meningitis, Bacterial/epidemiology , Adolescent , Adrenal Cortex Hormones/adverse effects , Adrenal Cortex Hormones/therapeutic use , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Drug Therapy, Combination , Female , Humans , Italy/epidemiology , Male , Meningitis, Bacterial/drug therapy , Meningitis, Bacterial/microbiology , Meningitis, Listeria/epidemiology , Meningitis, Meningococcal/epidemiology , Meningitis, Pneumococcal/epidemiology , Middle Aged , Retrospective Studies
6.
J Clin Pathol ; 53(2): 110-6, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10767825

ABSTRACT

AIM: To investigate the ultrastructural features of the newly hatched larvae of Strongyloides stercoralis in human duodenal mucosa. METHODS: Duodenal biopsies from an AIDS patient were studied by transmission electron microscopy to investigate morphology, location, and host-worm relations of newly hatched larvae. RESULTS: Newly hatched larvae were found in the Lieberkuhn crypts within the tunnels formed by migration of parthenogenic females. Delimiting enterocytes were compressed. Release of larvae into the gut lumen was also documented. It was shown that both a thin and a thick membrane surrounded the eggs and larvae, as a tegument derived respectively from parasite and host. Segmentary spike-like waves, caused by contractures of worm body musculature, were observed on the surface of newly hatched larvae, and their intestinal lumen was closed and empty, with no budding microvilli. Immaturity of the cuticle and some degree immaturity of amphidial neurones were found, but there was no evidence of either immaturity or signs of damage to other structures. CONCLUSIONS: Newly hatched larvae of S stercoralis appear to be a non-feeding immature stage capable of active movement through the epithelium, causing mechanical damage. The tegument resulting from the thin and the thick membrane may protect the parasite and reduce any disadvantage caused by immaturity.


Subject(s)
Duodenum/parasitology , Intestinal Diseases, Parasitic/pathology , Intestinal Mucosa/parasitology , Strongyloides stercoralis/ultrastructure , Strongyloidiasis/pathology , AIDS-Related Opportunistic Infections/parasitology , AIDS-Related Opportunistic Infections/pathology , Adult , Animals , Humans , Intestinal Diseases, Parasitic/parasitology , Larva/ultrastructure , Male , Microscopy, Electron , Strongyloidiasis/parasitology
7.
J Clin Pathol ; 51(10): 731-6, 1998 Oct.
Article in English | MEDLINE | ID: mdl-10023334

ABSTRACT

AIM: To investigate morphological changes in Enterocytozoon bieneusi and the duration of symptomatic relief after combination treatment with furazolidone and albendazole in AIDS patients. METHODS: Four severely immunocompromised AIDS patients with symptomatic E bieneusi infection of the gut received an 18 day course of combined furazolidone and albendazole (500 + 800 mg daily). All patients were monitored for parasite shedding in stool by light microscopy at the end of treatment and monthly during follow up. At the end of treatment, duodenal biopsy specimens obtained from three patients were studied by transmission electron microscopy by two pathologists blind to the patients' treatment or clinical outcome. Duodenal biopsy specimens obtained from one of the patients two months after completion of treatment were also studied electronmicroscopically. RESULTS: All patients had long lasting symptomatic relief, with a major decrease--or transient absence--of spore shedding in stools from completion of treatment. After treatment, changes in faecal spores were persistently found by light microscopy in all cases, and there was evidence of both a substantial decrease in the parasite load and ultrastructural damage in the parasite in all biopsy specimens. The treatment was well tolerated, and no patient had clinical or parasitological relapse during follow up (up to 15 months). CONCLUSIONS: The long lasting symptomatic relief observed in all four treated patients correlated with the persistent decrease in parasite load both in tissue and in stool, and with the morphological changes observed in the life cycle of the protozoan. These data suggest that combined treatment with furazolidone and albendazole is active against E bieneusi and may result in lasting remission even in severely immunocompromised patients.


Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , Albendazole/therapeutic use , Antiprotozoal Agents/therapeutic use , Furazolidone/therapeutic use , Microsporida/drug effects , Microsporidiosis/drug therapy , AIDS-Related Opportunistic Infections/parasitology , Adult , Animals , Drug Combinations , Feces/parasitology , Female , Follow-Up Studies , Humans , Intestinal Diseases, Parasitic/drug therapy , Male , Microsporida/ultrastructure , Microsporidiosis/parasitology
8.
J Clin Pathol ; 51(2): 138-42, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9602688

ABSTRACT

AIMS: To investigate the effectiveness of long term, low dose azithromycin treatment for chronic cryptosporidiosis in patients with AIDS. METHODS: Azithromycin was administered as initial daily treatment to 13 patients with AIDS: 6 patients received 500 mg for 30 to 40 days (mean 35); 3 patients received 1000 mg for 21 to 50 days (mean 37); and 4 patients received 1500 mg for 20 days. Nine of the 13 patients were also given low dose maintenance treatment with different schedules of azithromycin for 30 to 360 days (mean 129). Patients were monitored, during and after treatment, for parasite shedding in stool and for daily stool frequency and body weight. All but one patient had severe immunodeficiency. RESULTS: Long term, low dose maintenance treatment was associated with major clinical and parasitological benefits: there was probable eradication of infection in 2 patients, and 7 patients showed a complete response with persistent high decrease (5 patients) or clearance (2 patients) of parasite in stool. The drug was well tolerated, and there was no relapse either during treatment or during follow up (up to 21 months). These results were more impressive than those observed after the short term initial course of azithromycin, which was unable at any tested dose to achieve parasite clearance in stool (except in the patient with less advanced immunodeficiency) or to prevent relapse in 3 patients who discontinued treatment. Reversible side effects occurred with the 1500 mg daily dose. CONCLUSIONS: Long term, low dose azithromycin is well tolerated and may induce stable remission of chronic cryptosporidiosis in patients with AIDS. It may lead to probable eradication of the infection in some patients, even those with severe immunodeficiency.


Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Cryptosporidiosis/drug therapy , AIDS-Related Opportunistic Infections/immunology , Adult , CD4 Lymphocyte Count , Chronic Disease , Cryptosporidiosis/immunology , Drug Administration Schedule , Female , Follow-Up Studies , Humans , Male , Middle Aged , Treatment Outcome
9.
J Clin Pathol ; 50(6): 472-6, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9378811

ABSTRACT

AIMS: To investigate changes in morphology of the developmental stages of Enterocytozoon bieneusi and symptomatic relief observed in AIDS patients after treatment with furazolidone. METHODS: Six AIDS patients with symptomatic E bieneusi infection of the small intestine were treated with a course of furazolidone. All patients had a weekly monitoring of parasite shedding in stool by light microscopy during and after treatment. At the end of the treatment, duodenal biopsy specimens obtained from three patients were studied by transmission electron microscopy by two pathologists who were unaware of the patients' treatment. RESULTS: All patients showed both clinical and parasitological response with transient clearance or decrease of spore shedding in stool. After treatment, alterations in faecal spores were observed in all patients by light microscopy, and ultrastructural changes in E bieneusi at all stages of the life cycle were demonstrated in biopsy specimens of the three patients who underwent post-treatment endoscopy. CONCLUSIONS: The clinical benefit seen after treatment with furazolidone in six AIDS patients with E bieneusi intestinal infection may be due to damage to the developmental stages causing a partial inhibition to reproduction of the parasite.


Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , Anti-Bacterial Agents/therapeutic use , Furazolidone/therapeutic use , Intestinal Diseases, Parasitic/drug therapy , Microsporida/isolation & purification , Microsporidiosis/drug therapy , Adult , Animals , Feces/parasitology , Humans , Male , Spores
10.
Diagn Microbiol Infect Dis ; 18(1): 7-12, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8026160

ABSTRACT

Two strains of the newly proposed species "Mycobacterium genavense" have been isolated, using the radiometric system (Bactec, Becton Dickinson), from the blood of two HIV-infected patients. Disseminated infections due to the new organism closely resemble those of the Mycobacterium avium complex, with prevalently intestinal symptomatology. We report here on the cultural behavior of the isolates, which are enhanced at pH 6, are inhibited by NAP, do not require supplements, and grow best at 37 degrees C. We also report on the antibiotic susceptibility of the isolates.


Subject(s)
AIDS-Related Opportunistic Infections/microbiology , Mycobacterium Infections/microbiology , Mycobacterium/isolation & purification , Adult , Animals , Dogs , Humans , Male , Middle Aged , Mycobacterium/growth & development
11.
Psychiatry Res ; 81(2): 241-9, 1998 Nov 16.
Article in English | MEDLINE | ID: mdl-9858040

ABSTRACT

Although the expressions of both positive and negative symptoms in schizophrenia spectrum illnesses can each occur with varying degrees of severity, researchers have often dichotomized patients as generally positive or negative subtypes. Studies of schizophrenia and schizotypal personality disorder (SPD) have not typically controlled for the severity of the other symptom types when examining the relationship between positive and negative symptom subtypes and cognitive impairment. The present study investigated the relationship between the severity of both symptom types and reaction time crossover task performance in SPD in groups made equivalent on the severity of the other type of symptom. Fifty-eight out of 458 undergraduates were screened into one of four groups (high negative-high positive, low negative-low positive, high negative-low positive or low negative-high positive) by the Schizotypal Personality Questionnaire and assessed with the reaction time crossover task. The results indicated that negative schizotypal symptoms were associated with the early crossover pattern, while positive schizotypal symptoms related to longer overall reaction time. Therefore, different cognitive mechanisms involved in crossover task performance appeared to be associated with different symptom subtypes.


Subject(s)
Attention , Delusions/diagnosis , Depression/diagnosis , Psychiatric Status Rating Scales , Reaction Time , Schizotypal Personality Disorder/diagnosis , Adult , Delusions/psychology , Depression/psychology , Female , Humans , Male , Psychometrics , Schizotypal Personality Disorder/psychology , Students/psychology
12.
J Chemother ; 16(4): 334-6, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15332706

ABSTRACT

The new quinolone moxifloxacin was tested against 86 strains of Mycobacterium tuberculosis including 13 resistant and 4 multiresistant strains. The antimicrobial susceptibility was tested, in parallel, using two different liquid media, the radiometric Bactec 12B and the Mycobacteria Growth Indicator Tube (Becton Dickinson, USA). All strains but two were susceptible at 0.5 microg/ml of moxifloxacin; for the remaining two strains, both multidrugresistant, the minimal inhibitory concentrations (MIC) were =2 and >4 microg/ml respectively. Our data confirm the high antitubercular in vitro activity of moxifloxacin.


Subject(s)
Antibiotics, Antitubercular/pharmacology , Aza Compounds/pharmacology , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/isolation & purification , Quinolines/pharmacology , Drug Resistance, Bacterial , Drug Resistance, Multiple, Bacterial , Fluoroquinolones , Humans , Italy , Microbial Sensitivity Tests , Moxifloxacin , Sampling Studies , Sensitivity and Specificity
13.
Article in English | MEDLINE | ID: mdl-8863306

ABSTRACT

OBJECTIVES: To study the cause and clinical aspects of oral ulcers in HIV-infected patients. STUDY DESIGN: Forty-one consecutive HIV-positive patients with long-standing oral ulcers were examined; 19 were evaluated by biopsy. From these 19 cases, viral, bacterial, and fungal cultures and biopsies were taken in each patient. When indicated, special microbial stains were undertaken to identify bacteria or fungi. Ten cases without granulomatous bacterial fungal or lymphomatous features were available for in situ hybridization to detect viral DNA of herpes simplex virus 1 and 2, cytomegalovirus, varicella-zoster virus, and Epstein-Barr virus. RESULTS: Most of the oral ulcers occurred in patients with severe immunodepression. Median CD4 T-lymphocyte count was 60 cell/mm3 (range, 3 to 335). It was ascertained that nine (47%) patients had nonspecific aphthous-like ulcers, and ulcers caused by herpes group viruses were identified in six (31.5%) patients. One (5%) person was diagnosed with non-Hodgkin's lymphoma; and in one (5%) patient, multiple ulcers were an expression of lues maligna. Two ulcers (10.5%) in the palate harbored mycotic granulomatous foci (cryptococcosis, histoplasmosis). In this population, almost all of these ulcers were found to be large, persistent, and painful. CONCLUSIONS: Nontumefactive oral ulcers in HIV-positive patients may be a source of diagnostic difficulties because of the diverse array of underlying pathologic entities and multiplicity of etiologic agents. Biopsy should always be performed on long-standing ulcers because either infection or a neoplastic process may be extant. In the absence of infection or neoplasm, such lesions are then designated as ulcers not otherwise specified.


Subject(s)
HIV Infections/complications , Oral Ulcer/etiology , AIDS-Related Opportunistic Infections/microbiology , Adult , CD4 Lymphocyte Count , Cytomegalovirus/isolation & purification , Female , Herpesvirus 1, Human/isolation & purification , Herpesvirus 2, Human/isolation & purification , Humans , Lymphoma, AIDS-Related/complications , Male , Middle Aged , Mycoses/complications , Mycoses/etiology , Oral Ulcer/microbiology , Oral Ulcer/virology , Syphilis/complications , Syphilis/etiology
14.
Minerva Med ; 88(3): 117-9, 1997 Mar.
Article in Italian | MEDLINE | ID: mdl-9148227

ABSTRACT

We report one case of successful treatment of cerebral toxoplasmosis in acquired immunodeficiency syndrome (AIDS) with azithromycin combined with pyrimethamine. Toxoplasmic encephalitis had been diagnosed on the basis of multiple lesions exhibiting ring like contrast enhancement on double contrast Computed Tomographic (CT) scan of the brain. Thereby our patient had been treated with pyrimethamine 25 mg/die, after an attack dose of 100 mg in the first day, and clindamycin 2400 mg/die, because of sulfa-drug allergy, but clindamycin had to be discontinued because of rash development. At this point azithromycin, at a dose of 1000 mg/die for 21 days and 1500 mg a week for the following 50 days of follow-up, was added to pyrimethamine. Follow-up CT scan after 20 days of treatment (10 with clindamycin+pyrimethamine and 10 with azithromycin+pyrimethamine) revealed partial resolution of the brain lesions and subsequently (after 50 and 80 days of treatment) complete resolution.


Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Azithromycin/therapeutic use , Pyrimethamine/therapeutic use , Toxoplasmosis, Cerebral/drug therapy , Drug Therapy, Combination , Humans , Male , Middle Aged
15.
Minerva Med ; 87(3): 113-5, 1996 Mar.
Article in Italian | MEDLINE | ID: mdl-8668287

ABSTRACT

STUDY OBJECTIVE: A fairly uncommon case of neurosyphilis is reported in a not immunocompromised patient. CASE REPORT: A case of general paresis in a 40 year-old male with the recent onset of mania is described. Psychiatric anamnesis was negative. Neurologic examination was negative. Laboratory tests were performed and serologic tests for syphilis were positive. Cerebrospinal fluid (CSF) examination showed 80 leukocytes/mm3, a reactive Venereal Disease Research Laboratory (VDRL) and normal protein concentration. CSF gamma globulin with an oligoclonal pattern and abnormal IgG index were found. A test for antibodies to Human Immunodeficiency Virus (HIV) was negative. The patient underwent a high dose intravenous penicillin G regimen for two weeks. A follow-up six months later showed a normal CSF even though the IgG index was still abnormal and the mental status was unchanged. CONCLUDING REMARKS: The authors suggest that patients with neurologic and/or psychiatric symptoms with a recent onset and a reactive VDRL should undergo a CSF examination to exclude a possible neurosyphilis.


Subject(s)
Neurosyphilis , Adult , Cerebrospinal Fluid Proteins/analysis , Diagnosis, Differential , Follow-Up Studies , Humans , Immunoglobulin G/cerebrospinal fluid , Injections, Intravenous , Male , Neurosyphilis/cerebrospinal fluid , Neurosyphilis/diagnosis , Penicillin G/administration & dosage , Syphilis Serodiagnosis , Time Factors , gamma-Globulins/cerebrospinal fluid
16.
Recenti Prog Med ; 81(7-8): 493-8, 1990.
Article in Italian | MEDLINE | ID: mdl-2247696

ABSTRACT

Two imported cases of amebic liver abscess are discussed with regard to laboratory, diagnostic and therapeutic peculiarities. The diagnostic role of ultrasonography and especially of specific serology is stressed, whereas in therapeutic terms, the efficacy of medical approach alone is emphasized even when complications until yesterday surgically treated occur.


Subject(s)
Liver Abscess, Amebic , Liver Abscess, Amebic/diagnosis , Adult , Animals , Antiprotozoal Agents/therapeutic use , Entamoeba histolytica , Humans , Liver Abscess, Amebic/therapy , Male , Tomography, X-Ray Computed , Ultrasonography
17.
Recenti Prog Med ; 82(7-8): 385-9, 1991.
Article in Italian | MEDLINE | ID: mdl-1947403

ABSTRACT

An imported case of intestinal schistosomiasis in AIDS is analysed by the relationships between immune response, diagnostic methods, pathogenetic mechanisms. The inconclusiveness of negative results from both serology and stool parasitology is remarked whereas the efficacy of associated histological, histochemical and immunohistochemical methods is emphasized in order to get better data on aetiological diagnosis and on cell types and size of reactive granulomas. In the case studied, negative serology, absent fecal egg excretion and uneffective granulomatous response with scarcity of T and B lymphocytes have been documented by means of the above methods.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Proctocolitis/etiology , Schistosomiasis mansoni/diagnosis , Adult , Humans , Immunohistochemistry , Male , Proctocolitis/diagnosis , Proctocolitis/pathology , Schistosomiasis mansoni/pathology
18.
Recenti Prog Med ; 86(10): 394-7, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7501904

ABSTRACT

The efficacy of furazolidone for treatment of intestinal microsporidiosis due to Enterocytozoon bieneusi was studied in three patients with AIDS. All patients had chronic diarrhoea and weight loss. Mean CD4 cell count was 34.6/mm3. A course of furazolidone (100 mg orally four times a day) was given for 20 days. The drug was well tolerated and neither side effects nor alterations in the laboratory parameters were noted. Diarrhoea ceased within a mean of 12 days of starting treatment and clearance of microsporidian shedding in stool was observed. In one of the patients, however, symptomatic microsporidiosis recurred. Therefore furazolidone seems to have a transient but significant effect on intestinal infection due to Enterocytozoon bieneusi.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Anti-Infective Agents, Local/therapeutic use , Furazolidone/therapeutic use , Intestinal Diseases, Parasitic/drug therapy , Microsporida , Microsporidiosis/drug therapy , Adult , Animals , Anti-Infective Agents, Local/administration & dosage , Furazolidone/administration & dosage , Humans , Male , Time Factors
19.
Recenti Prog Med ; 80(2): 92-8, 1989 Feb.
Article in Italian | MEDLINE | ID: mdl-2652226

ABSTRACT

The Authors focused on the new isolates' important role in human infections (particularly pylori, laridis, hyointestinalis and Campylobacters like- organisms) by clinical, microbiological and research data. Recent knowledge about pathogenetic mechanisms of classical Campylobacters is also reported.


Subject(s)
Campylobacter Infections , Campylobacter , Campylobacter/drug effects , Campylobacter/metabolism , Campylobacter/pathogenicity , Campylobacter Infections/epidemiology , Campylobacter Infections/microbiology , Humans
20.
Recenti Prog Med ; 85(11): 526-36, 1994 Nov.
Article in Italian | MEDLINE | ID: mdl-7855386

ABSTRACT

Digestive apparatus is a common target of atypical mycobacteriosis in AIDS patients (at least 50% of patients with CD4+ lymphocytes < 50/mm3). We describe the clinical-histological features of two cases of Whipple-like syndrome likely caused by Mycobacterium avium (MAI) (study performed by light and electron microscopy), of one case of infection caused by two morphological variants of a MAI strain with a different sensitivity to antibiotics, of one case of M. kansasii infection and of two cases of M. genavense infection accompanied by sensitivity tests to antibiotics (as far as we know, these are the first described quantitative sensitivity tests of M. genavense to antibiotics). In conclusion, we discuss the present therapeutical outlines for M. kansasii and avium, together with the teramporary pharmacological options for M. genavense as suggested by antibiotic sensitivity tests performed on the strains isolated from the studied patients.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Antitubercular Agents/therapeutic use , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium avium , Tuberculosis, Gastrointestinal/drug therapy , Adult , Female , Humans , Male , Microbial Sensitivity Tests , Mycobacterium Infections, Nontuberculous/complications , Tuberculosis, Gastrointestinal/complications
SELECTION OF CITATIONS
SEARCH DETAIL